HU9401446D0 - Purified heparin fractions process for producing them and pharmaceutical compositions containing them - Google Patents

Purified heparin fractions process for producing them and pharmaceutical compositions containing them

Info

Publication number
HU9401446D0
HU9401446D0 HU9401446A HU9401446A HU9401446D0 HU 9401446 D0 HU9401446 D0 HU 9401446D0 HU 9401446 A HU9401446 A HU 9401446A HU 9401446 A HU9401446 A HU 9401446A HU 9401446 D0 HU9401446 D0 HU 9401446D0
Authority
HU
Hungary
Prior art keywords
producing
pharmaceutical compositions
compositions containing
heparin fractions
purified heparin
Prior art date
Application number
HU9401446A
Other languages
English (en)
Other versions
HU221595B (hu
HUT70553A (en
Inventor
Jean-Francois Branellec
Jose Espejo
Philippe Picart
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU9401446(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay Sa filed Critical Choay Sa
Publication of HU9401446D0 publication Critical patent/HU9401446D0/hu
Publication of HUT70553A publication Critical patent/HUT70553A/hu
Publication of HU221595B publication Critical patent/HU221595B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
HU9401446A 1993-05-07 1994-05-06 Tisztított heparinfrakciók, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények HU221595B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (3)

Publication Number Publication Date
HU9401446D0 true HU9401446D0 (en) 1994-08-29
HUT70553A HUT70553A (en) 1995-10-30
HU221595B HU221595B (hu) 2002-11-28

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401446A HU221595B (hu) 1993-05-07 1994-05-06 Tisztított heparinfrakciók, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények

Country Status (26)

Country Link
US (1) US5599801A (hu)
EP (1) EP0623629B1 (hu)
JP (1) JP3529835B2 (hu)
KR (1) KR100328095B1 (hu)
CN (1) CN1066155C (hu)
AT (1) ATE141618T1 (hu)
AU (1) AU672291B2 (hu)
BR (1) BR9401920A (hu)
CA (1) CA2122930C (hu)
CZ (1) CZ287889B6 (hu)
DE (1) DE69400385T2 (hu)
DK (1) DK0623629T3 (hu)
ES (1) ES2093494T3 (hu)
FI (1) FI107388B (hu)
FR (1) FR2704861B1 (hu)
GR (1) GR3021648T3 (hu)
HK (1) HK1007432A1 (hu)
HU (1) HU221595B (hu)
IL (1) IL109587A (hu)
MY (1) MY110862A (hu)
NO (1) NO306952B1 (hu)
NZ (1) NZ260460A (hu)
PL (1) PL178294B1 (hu)
RU (1) RU2133253C1 (hu)
TW (1) TW438812B (hu)
ZA (1) ZA943152B (hu)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2341412A1 (en) * 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
CA2643162C (en) * 1999-04-23 2018-01-02 Massachusetts Institute Of Technology Polymer identification, compositional analysis and sequencing, based on property comparison
WO2001066772A2 (en) 2000-03-08 2001-09-13 Massachusetts Institute Of Technology Heparinase iii and uses thereof
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
WO2002023190A2 (en) 2000-09-12 2002-03-21 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
JP2004523479A (ja) * 2000-10-18 2004-08-05 マサチューセッツ　インスティテュート　オブ　テクノロジー 多糖の肺送達に関する方法および産物
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
EP2284535A1 (en) 2002-03-11 2011-02-16 Momenta Pharmaceuticals, Inc. Low molecular weight heparins
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
CN102791742B (zh) * 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
EP3144325B1 (en) * 2010-09-14 2020-11-04 University Of Miyazaki High purity heparin and production method therefor
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
CN111727204B (zh) * 2018-02-14 2023-01-31 生物E有限公司 用于制备达肝素钠的改进方法
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
EP4182452A1 (en) 2020-07-14 2023-05-24 Optimvia, LLC Methods for synthesizing non-anticoagulant heparan sulfate
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
IL109587A (en) 1997-04-15
IL109587A0 (en) 1994-08-26
DE69400385T2 (de) 1996-12-19
NO941686L (no) 1994-11-08
JP3529835B2 (ja) 2004-05-24
TW438812B (en) 2001-06-07
FI942095A0 (fi) 1994-05-06
AU672291B2 (en) 1996-09-26
CN1096034A (zh) 1994-12-07
AU6191294A (en) 1994-11-10
ZA943152B (en) 1995-01-09
NO941686D0 (no) 1994-05-06
BR9401920A (pt) 1994-11-29
CZ287889B6 (cs) 2001-03-14
HK1007432A1 (en) 1999-04-09
EP0623629B1 (fr) 1996-08-21
PL178294B1 (pl) 2000-04-28
ATE141618T1 (de) 1996-09-15
EP0623629A1 (fr) 1994-11-09
US5599801A (en) 1997-02-04
HU221595B (hu) 2002-11-28
CN1066155C (zh) 2001-05-23
CZ113294A3 (en) 1994-12-15
FI942095A (fi) 1994-11-08
CA2122930C (en) 2000-10-24
JPH07126302A (ja) 1995-05-16
NZ260460A (en) 1996-02-27
DK0623629T3 (da) 1996-12-23
FI107388B (fi) 2001-07-31
FR2704861A1 (fr) 1994-11-10
KR100328095B1 (ko) 2002-06-20
RU94015595A (ru) 1996-09-27
DE69400385D1 (de) 1996-09-26
NO306952B1 (no) 2000-01-17
HUT70553A (en) 1995-10-30
CA2122930A1 (en) 1994-11-08
GR3021648T3 (en) 1997-02-28
FR2704861B1 (fr) 1995-07-28
ES2093494T3 (es) 1996-12-16
MY110862A (en) 1999-05-31
RU2133253C1 (ru) 1999-07-20

Similar Documents

Publication Publication Date Title
HU9401446D0 (en) Purified heparin fractions process for producing them and pharmaceutical compositions containing them
TW354793B (en) Polycarbonate resin with high flowability and process for producing the same
ZA949873B (en) Production of pentafluoroethane
BR9205473A (pt) Processo de reduzir a degradacao de irradiacao ultravioleta,e composicao de polimero
ES2072163T3 (es) Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina.
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
AU8320191A (en) Peroxyacid clathrates, their production and use
ZA958157B (en) Process for the manufacture of starch break-down products
AU6235890A (en) Purification of 1,1-dichloro-1-fluoroethane
AU3492289A (en) Fluorine-containing copolymer, process for its production and curable composition
AU1985192A (en) A method of generating high carotenoid-producing microorganisms, microorganisms obtained by the method and a process for producing carotenoid-containing cells or cell parts or purified carotenoid
EP0704285A3 (en) Process for the production of coated wood fiber boards with rounded edges and boards produced by this process
EP0626199A3 (en) Process for the production of carbon molecular sieves.
AU4373889A (en) Improved process for the preparation of 1,1,1,2- tetrafluoroethane
BR9408287A (pt) Processo para fabricar resina de poliamina-epicloro-hidrina e produto produzido pelo processo
ATE141614T1 (de) Neue peptidderivate im prozess von zelladhäsion wirksam, verfahren zur deren herstellung und pharmazeutische zusammensetzungen die sie enthalten
DK0566190T3 (hu)
HU208255B (en) Process for producing medicinal compositions suitable for treating herpes simplex
LV5780B4 (lv) Pretkonvulsiji triazolÚ4,5-c¾piridina atvasinajumi
MY129219A (en) Stabilization of lacquers
ITMI913034A1 (it) Metodo per il trattamento chimico di tutte le sostanze organiche con un prodotto atto ad eliminare in modo rapido gli odori da esse emanati e per l'impiego del composto risultante come fertilizzante
PL294134A1 (en) Method of obtaining 1,1,2-trichloroethane from waste fractions present in vinyl chlorode production process

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: SANOFI-SYNTHELABO, FR